
Led by Roshanak Monzavi, MD, the TrialNet team at Childrens Hospital Los Angeles is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Note: As a TrialNet affiliate, Childrens Hospital Los Angeles is regionally overseen by University of California - San Francisco. If you reach out to TrialNet, you may be contacted by staff from either institution.
Nuestro Equipo

Roshanak Monzavi, MD
Principal InvestigatorDr. Monzavi is an associate professor of clinical pediatrics at the Center for Endocrinology, Diabetes, and Metabolism at Children’s Hospital Los Angeles (CHLA). She completed her residency training at University of California, Irvine in 2001, and her fellowship training at CHLA in 2004. She joined the division as a faculty member in November 2005. Her main clinical interests are in care of patients with Type 1 diabetes and general endocrine disorders. She sees patients at CHLA as well as CHLA's Encino Care Center. Dr. Monzavi is the director of Pediatric Endocrinology Fellowship Program, and the recipient of the Gustavus and Louise Pfeiffer Research Foundation award to the fellowship program. She is involved in many educational activities involving fellows, residents, and medical students. She is also co-director of medical education for medical students and residents within the division of endocrinology. Dr. Monzavi’s main research interests are clinical care and immunomodulatory therapies for Type 1 Diabetes. She has been the site Principal Investigator (PI) for TrialNet consortium since 2009, and site PI for many clinical trials through Jaeb Center since 2016. She has co-authored multiple research papers involving multi-center trials led by these consortia.

Jennifer Raymond, MD
Sub- InvestigatorDr. Raymond is an Associate Professor of Clinical Pediatrics, Chair of the Virtual Care Committee, and Chief of the Division of Endocrinology with a research and clinical focus on improving patient outcomes through novel clinical approaches and behavioral interventions, including projects focused on clinician-patient interactions. She is an expert in utilizing shared medical appointments (virtual and in-person), telehealth, and clinical and behavioral person-centered care interventions to increase participation of marginalized populations living with diabetes. Dr. Raymond is currently funded by the National Institute of Health and the Leona M. and Harry B. Helmsley Charitable Trust to investigate innovative clinical interventions in historically excluded, marginalized, and ethnically and racially diverse populations living with diabetes. This work involves the use of virtual peer groups and person-centered care approaches to engage and improve outcomes in the lives of young people living with diabetes.
Over the past 12 years at Children’s Hospital Los Angeles (CHLA) and the Barbara Davis Center (BDC) in Colorado, Dr. Raymond has developed strong collaborations and successful working relationships with diverse multidisciplinary teams, including diabetes educators, social workers, dietitians, occupational therapists, dissemination and implementation experts, psychologists, statisticians, public health experts, scientific researchers with extensive clinical research experience, and endocrinologists to develop innovative and culturally appropriate models for unique populations. Her team has also provided multiple opportunities for students and fellows from different disciplines (e.g., clinical research coordinators, pre-doctoral students, PhDs, fellows, physicians, post-doctoral students, undergraduates) to learn alongside them from the development to implementation stages of projects. Their successful and extensive experiences and the diversity of the team increases their potential for success and creates an optimal learning environment. Additionally, during her time at CHLA, Dr. Raymond’s research projects have provided great insight into successful recruitment, implementation, and retention approaches for research in historically excluded, marginalized, and ethnically and racially diverse young people living with diabetes.
